• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

共同失调的通路导致帕金森病和糖尿病。

Shared dysregulated pathways lead to Parkinson's disease and diabetes.

机构信息

The Cellular and Molecular Pharmacology Department, The Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.

出版信息

Trends Mol Med. 2013 Mar;19(3):176-86. doi: 10.1016/j.molmed.2013.01.002. Epub 2013 Jan 31.

DOI:10.1016/j.molmed.2013.01.002
PMID:23375873
Abstract

Recent evidence indicates that Parkinson's disease and diabetes, both age-related chronic diseases, share remarkably similar dysregulated pathways. Exposure to environmental factors and genetic susceptibility play a role in the etiology and progression of both diseases. In light of recent findings, an intriguing hypothesis has emerged that suggests that mitochondrial dysfunction, endoplasmic reticulum stress, inflammation, and alterations in metabolism may lead to insulin resistance and, ultimately, to diabetes and/or neurodegeneration. In this article, we summarize the studies that have addressed the relationship between Parkinson's disease and diabetes and propose that disruptions in these shared molecular networks lead to both chronic diseases.

摘要

最近的证据表明,帕金森病和糖尿病这两种与年龄相关的慢性疾病,有着显著相似的失调途径。环境因素暴露和遗传易感性在这两种疾病的病因和进展中都起着作用。鉴于最近的发现,出现了一个有趣的假设,即线粒体功能障碍、内质网应激、炎症和代谢改变可能导致胰岛素抵抗,最终导致糖尿病和/或神经退行性变。在本文中,我们总结了探讨帕金森病和糖尿病之间关系的研究,并提出这些共同的分子网络的破坏导致了这两种慢性疾病。

相似文献

1
Shared dysregulated pathways lead to Parkinson's disease and diabetes.共同失调的通路导致帕金森病和糖尿病。
Trends Mol Med. 2013 Mar;19(3):176-86. doi: 10.1016/j.molmed.2013.01.002. Epub 2013 Jan 31.
2
System-based approaches to decode the molecular links in Parkinson's disease and diabetes.基于系统的方法来解码帕金森病和糖尿病中的分子联系。
Neurobiol Dis. 2014 Dec;72 Pt A:84-91. doi: 10.1016/j.nbd.2014.03.019. Epub 2014 Apr 6.
3
Heredity in Parkinson's disease: new findings.帕金森病的遗传:新发现
Isr Med Assoc J. 2001 Jun;3(6):435-8.
4
Dementia is associated with insulin resistance in patients with Parkinson's disease.痴呆与帕金森病患者的胰岛素抵抗有关。
J Neurol Sci. 2012 Apr 15;315(1-2):39-43. doi: 10.1016/j.jns.2011.12.008. Epub 2012 Jan 21.
5
Parkinson's disease, insulin resistance and novel agents of neuroprotection.帕金森病、胰岛素抵抗与神经保护新制剂。
Brain. 2013 Feb;136(Pt 2):374-84. doi: 10.1093/brain/aws009. Epub 2012 Feb 17.
6
Mitochondrial pathology in Parkinson's disease.帕金森病中的线粒体病理学
Mt Sinai J Med. 2011 Nov-Dec;78(6):872-81. doi: 10.1002/msj.20303.
7
Mitochondrial genotypes and cytochrome b variants associated with longevity or Parkinson's disease.与长寿或帕金森病相关的线粒体基因型和细胞色素b变体。
J Neurol. 2002 Sep;249 Suppl 2:II11-8. doi: 10.1007/s00415-002-1203-5.
8
Meta-analysis of genetic and environmental Parkinson's disease models reveals a common role of mitochondrial protection pathways.遗传和环境帕金森病模型的荟萃分析揭示了线粒体保护途径的共同作用。
Neurobiol Dis. 2012 Mar;45(3):1018-30. doi: 10.1016/j.nbd.2011.12.021. Epub 2011 Dec 16.
9
Molecular pathogenesis of Parkinson's disease.帕金森病的分子发病机制
Hum Mol Genet. 2005 Sep 15;14(18):2749-55. doi: 10.1093/hmg/ddi308. Epub 2005 Aug 26.
10
Dysfunction of dopamine homeostasis: clues in the hunt for novel Parkinson's disease therapies.多巴胺动态平衡失调:探寻新型帕金森病治疗方法的线索。
FASEB J. 2013 Jun;27(6):2101-10. doi: 10.1096/fj.12-226852. Epub 2013 Mar 5.

引用本文的文献

1
The Inflammatory Bridge Between Type 2 Diabetes and Neurodegeneration: A Molecular Perspective.2型糖尿病与神经退行性变之间的炎症桥梁:分子视角
Int J Mol Sci. 2025 Aug 5;26(15):7566. doi: 10.3390/ijms26157566.
2
Plasma Metabolomics Profiles in Prodromal and Clinical Parkinson's Disease.前驱期和临床期帕金森病的血浆代谢组学特征
Mov Disord. 2025 Aug 13. doi: 10.1002/mds.30308.
3
Untargeted Lipidomic Reveals Potential Biomarkers in Plasma Samples for the Discrimination of Patients Affected by Parkinson's Disease.非靶向脂质组学揭示血浆样本中用于鉴别帕金森病患者的潜在生物标志物。
Molecules. 2025 Feb 12;30(4):850. doi: 10.3390/molecules30040850.
4
Parkinson's disease and glucose metabolism impairment.帕金森病与葡萄糖代谢障碍。
Transl Neurodegener. 2025 Feb 17;14(1):10. doi: 10.1186/s40035-025-00467-8.
5
Evolving Landscape of Parkinson's Disease Research: Challenges and Perspectives.帕金森病研究的发展态势:挑战与展望
ACS Omega. 2025 Jan 8;10(2):1864-1892. doi: 10.1021/acsomega.4c09114. eCollection 2025 Jan 21.
6
Understanding glucose metabolism and insulin action at the blood-brain barrier: Implications for brain health and neurodegenerative diseases.了解血脑屏障处的葡萄糖代谢和胰岛素作用:对脑健康和神经退行性疾病的影响。
Acta Physiol (Oxf). 2025 Feb;241(2):e14283. doi: 10.1111/apha.14283.
7
Glucose Metabolism Disorders and Parkinson's Disease: Coincidence or Indicator of Dysautonomia?葡萄糖代谢紊乱与帕金森病:巧合还是自主神经功能障碍的指标?
Healthcare (Basel). 2024 Dec 6;12(23):2462. doi: 10.3390/healthcare12232462.
8
The Interplay of Stress, Inflammation, and Metabolic Factors in the Course of Parkinson's Disease.应激、炎症和代谢因素在帕金森病病程中的相互作用。
Int J Mol Sci. 2024 Nov 19;25(22):12409. doi: 10.3390/ijms252212409.
9
Exploring the Antidiabetic Potential of Using Network Pharmacology, Molecular Docking and ADME/Drug-Likeness Predictions.利用网络药理学、分子对接以及ADME/药物相似性预测探索抗糖尿病潜力
Plants (Basel). 2024 Oct 16;13(20):2892. doi: 10.3390/plants13202892.
10
Cardiovascular dysautonomia and cognitive impairment in Parkinson's disease (Review).帕金森病中的心血管自主神经功能障碍与认知障碍(综述)
Med Int (Lond). 2024 Sep 19;4(6):70. doi: 10.3892/mi.2024.194. eCollection 2024 Nov-Dec.